MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Sleep disorders. See also Restless legs syndrome: Pathophysiology"

  • 2018 International Congress

    Association of impaired melatonin secretion with sleep disturbance in multiple system atrophy

    T. Nakamura, M. Ueda, M. Suzuki, E. Imai, G. Tohnai, M. Katsuno (Nagoya, Japan)

    Objective: To clarify whether there is impaired melatonin secretion and whether it is associated with sleep disturbance in patients with multiple system atrophy (MSA). Background:…
  • 2018 International Congress

    Turkish version of the Johns Hopkins Restless Legs Syndrome Quality of Life Questionnaire (RLS-QoL): Validity and reliability study

    S. Güler, N. Turan (Edirne, Turkey)

    Objective: RLS has an extremely negative effect on the quality of life and sleep patterns of patients (1). In this study, we aimed to analyse…
  • 2017 International Congress

    Circadian and Homeostatic Modulation of Multi-unit Activity in Dopaminergic and Striatal Structures

    K. Fifel (Leiden, Netherlands)

    Objective: The aim of this study is to investigate the circadian and homeostatic modulation of the multi-unit activity of dopamineric and striatal neuronal structures. Background:…
  • 2017 International Congress

    Association of impaired melatonin secretion with sleep disturbance in Parkinson’s disease

    T. Nakamura, M. Suzuki, M. Ueda, E. Imai, G. Tohnai, M. Katsuno (Nagoya, Japan)

    Objective: To clarify if impaired melatonin secretion is associated with daytime or nighttime sleep disturbances in patients with Parkinson’s disease (PD). Background: PD is associated…
  • 2017 International Congress

    Histological analysis of α-synuclein pathology in the circadian system in Parkinson’s disease

    E. De Pablo-Fernandez, J. Holton, T. Warner (London, United Kingdom)

    Objective: Assessment of severity of α-synuclein pathology in the circadian system in patients with Parkinson’s disease (PD). Background: Circadian system is responsible for the 24-hour…
  • 2017 International Congress

    Association of CSF biomarkers with motor and non-motor features in moderately advanced Parkinson’s disease cohort: the BioFIND study

    J. Goldman, A. Amara, L. Shaw, P. Taylor, H. Andrews, R. Alcalay, T. Xie, P. Tuite, C. Henchcliffe, P. Hogarth, S. Frank, M.-H. Saint Hilaire, A. Naito, M. Frasier, V. Arnedo, A. Reimer, M. Sutherland, C. Swanson-Fischer, K. Gwinn, U. Kang (Chicago, IL, USA)

    Objective: Evaluate associations between CSF biomarkers of neurodegeneration and clinical phenotype in Parkinson’s disease (PD) participants of the BioFIND cohort.  Background: Levels of CSF α-synuclein…
  • 2017 International Congress

    Sleep architecture in Parkinson´s disease and Parkinson’s disease associated dementia

    L. Sousa, I. Laranjinha, J. Lopes, J. Ramalheira, A.M. da Silva, A.B. Lima, M. Magalhães (Porto, Portugal)

    Objective: To evaluate the differences in early sleep architecture between patients with Parkinson’s disease (PD) and Parkinson’s disease associated dementia (PDD). Background: Disorders of sleep…
  • 2016 International Congress

    Comparative study of the substantia nigra echogenicity and 123-I ioflupane SPECT in patients with REM behavior disorder

    J. Mašková, P. Dušek, D. Školoudík, K. Kupka, K. Šonka, V. Ibarburu Lorenzo Y Losada, J. Kubinyi, E. Ruzicka (Praha 2, Czech Republic)

    Objective: To compare (1) the echogenicity of substantia nigra (SN) in subjects with idiopathic REM behavior disorder (iRBD) and healthy controls and (2) to determine…
  • 2016 International Congress

    Circadian dysfunction in Parkinson’s disease: Effects on impaired gait initiation and locomotion

    L. Alibiglou, J. Stewart, G. Bachman, C. Cooper, L. Liu, S. Ancoli-Israel (Chicago, IL, USA)

    Objective: To investigate the impact of circadian rhythm (CR) and time of the day on the magnitude of motor impairments during gait initiation and continuation…
  • « Previous Page
  • 1
  • 2
  • 3

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley